Financial News
Verve Therapeutics Inc (NQ: VERV )
5.230
-0.050
(-0.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Headline News about Verve Therapeutics Inc
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/13/image_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ARK_Photo_by_Ira_Lichi_on_Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Verve Therapeutics's Return On Capital Employed Insights
March 08, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/708218/scientist-looking-through-microscope.jpg)
![](https://g.foolcdn.com/editorial/images/721399/dna-genetic-sequencing-biotech-1.jpg)
![](https://g.foolcdn.com/editorial/images/720699/dna-research-concept.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/01/verv_logo_light__275e9401a6b8fe6d5a24270564eff9aa.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2531.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/shutterstock_1179311608.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2723.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-crispr-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/20/aapharma_11.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/15/image-third_harmonic_bio_.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/713120/gettycelebratingwomanphone.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/07/shutterstock_1926863363.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30794.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image-vf_corp.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image44.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/10/Stock-vervetherapeutics-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22059.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image44.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20875.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20868.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image14.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.